Birdwatch Note Rating
2024-05-20 16:21:09 UTC - NOT_HELPFUL
Rated by Participant: FD6ABB2E1CEA98185C5C2C6A8E8AC4AA96B28ADAF8BF7C9BC2FD72556D1CB01A
Participant Details
Original Note:
No, the Ebola clinical trial involving the COVID-19 drug Remdesivir did not show Remdesivir had a 50% mortality rate. This is a false interpretation of the study. The study showed that Ebola infection had a 53% mortality rate. Ebola can have up to a 90% mortality rate https://nejm.org/doi/full/10.1056/nejmoa1910993 https://paho.org/en/topics/ebola-virus-disease
All Note Details